3 Cancer Stocks to Watch Amidst Rising Incidence and Advances in Treatment

The oncology market is set for rapid growth due to rising cancer incidence and scientific advancements. Pharmaceutical companies are investing aggressively in immunotherapies, targeted treatments, and personalized vaccines. J&J, ImmunityBio, and Foghorn Therapeutics are among the stocks to consider, with J&J's Oncology segment accounting for 27% of its total revenues and its sales rising 20.6% in the first nine months.